Japan's FY26 budget hits ¥122T, a record high. Traders eye inflation & growth impacts on yen.
GOOGL +64% return eyed; NVDA +38%, GLDM +69%. Traders eye AI & gold for holiday gains.
AI stocks like NVDA surge on $20B deal talk; SNOW M&A buzz. Traders eye hardware vs. software split & concentration risks.
MindMed (MNMD) surges 87% on strong trial data & $61 price target; losses widen but cash runway extends.
Nvidia's China market share hits zero; rare earth controls tighten. AI race intensifies, risking bubble.
Annualized return (the real average growth rate each year) to show that the U.S. stock market has been much more profitable in recent decades than over its 155-year history.
NVO's oral Wegovy pill gains FDA approval, a redemption after a 39% 2025 drop. Analysts see potential 33% upside.
Sponsored
Must Read